GF
CYTK icon

Gabelli Funds’s Cytokinetics CYTK Stock Holding History

Gabelli Funds’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Buy
15,209
+1,000
+7% +$63.6K 0.01% 893
2025
Q4 		$903K Sell
14,209
-20,550
-59% -$1.28M 0.01% 933
2025
Q3 		$1.91M Buy
34,759
+26,349
+313% +$1.09M 0.01% 763
2025
Q2 		$278K Buy
8,410
+1,910
+29% +$66.4K ﹤0.01% 1100
2025
Q1 		$261K Buy
6,500
+1,500
+30% +$68.9K ﹤0.01% 979
2024
Q4 		$235K Sell
5,000
-400
-7% -$20.8K ﹤0.01% 1000
2024
Q3 		$285K Buy
5,400
+400
+8% +$22.3K ﹤0.01% 965
2024
Q2 		$271K Hold
5,000
– – ﹤0.01% 958
2024
Q1 		$351K Buy
+5,000
New +$387K ﹤0.01% 930

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return